Infante Jeffrey R, Cohen Roger B, Kim Kevin B, Burris Howard A, Curt Gregory, Emeribe Ugochi, Clemett Delyth, Tomkinson Helen K: A phase I dose-escalation study of Selumetinib in combination with Erlotinib or Temsirolimus in patients with advanced solid tumors. Investigational new drugs : 2017.
Bagley Stephen J, Kothari Shawn, Aggarwal Charu, Bauml Joshua M, Alley Evan W, Evans Tracey L, Kosteva John A, Ciunci Christine A, Gabriel Peter E, Thompson Jeffrey C, Stonehouse-Lee Susan, Sherry Victoria E, Gilbert Elizabeth, Eaby-Sandy Beth, Mutale Faith, DiLullo Gloria, Cohen Roger B, Vachani Anil: Pretreatment neutrophil-to-lymphocyte ratio as a marker of outcomes in nivolumab-treated patients with advanced non-small-cell lung cancer. Lung cancer (Amsterdam, Netherlands) 106 : 1-7,2017.
LoRusso Patricia M, Infante Jeffrey R, Kim Kevin B, Burris Howard A, Curt Gregory, Emeribe Ugochi, Clemett Delyth, Tomkinson Helen K: A phase I dose-escalation study of selumetinib in combination with docetaxel or dacarbazine in patients with advanced solid tumors. BMC cancer 17 (1): 173,2017.
Bauml Joshua, Kim Jiyoung, Zhang Xiaochen, Aggarwal Charu, Cohen Roger B: Unsupervised exercise in survivors of human papillomavirus related head and neck cancer: how many can go it alone? Journal of cancer survivorship : research and practice : 2017.
Ott P A, Piha-Paul S A, Munster P, Pishvaian M J, van Brummelen E M J, Cohen R B, Gomez-Roca C, Ejadi S, Stein M, Chan E, Simonelli M, Morosky A, Saraf S, Emancipator K, Koshiji M: Safety and antitumor activity of the anti-PD-1 antibody pembrolizumab in patients with recurrent carcinoma of the anal canal. Annals of oncology : official journal of the European Society for Medical Oncology : 2017.
Infante Jeffrey R, Patnaik Amita, Verschraegen Claire F, Olszanski Anthony J, Shaheen Montaser, Burris Howard A, Tolcher Anthony W, Papadopoulos Kyriakos P, Beeram Muralidhar, Hynes Scott M, Leohr Jennifer, Lin Aimee Bence, Li Lily Q, McGlothlin Anna, Farrington Daphne L, Westin Eric H: Two Phase 1 dose-escalation studies exploring multiple regimens of litronesib (LY2523355), an Eg5 inhibitor, in patients with advanced cancer. Cancer chemotherapy and pharmacology 79 (2): 315-326,2017.
Hatten Kyle M, O'Malley Bert W, Bur Andres M, Patel Mihir R, Rassekh Christopher H, Newman Jason G, Cannady Steven B, Chalian Ara A, Hodnett Benjamin L, Lin Alexander, Lukens John N, Cohen Roger B, Bauml Joshua M, Montone Kathleen T, Livolsi Virginia A: Transoral Robotic Surgery-Assisted Endoscopy With Primary Site Detection and Treatment in Occult Mucosal Primaries. JAMA otolaryngology-- head & neck surgery 143 (3): 267-273,2016.
Bagley Stephen J, Vitale Steven, Zhang Suhong, Aggarwal Charu, Evans Tracey L, Alley Evan W, Cohen Roger B, Langer Corey J, Blair Ian A, Vachani Anil: Pretreatment Red Blood Cell Total Folate Concentration Is Associated With Response to Pemetrexed in Stage IV Nonsquamous Non-Small-cell Lung Cancer. Clinical lung cancer 18 (2): e143-e149,2016.
Bauml Joshua M, Troxel Andrea, Epperson C Neill, Cohen Roger B, Schmitz Kathryn, Stricker Carrie, Shulman Lawrence N, Bradbury Angela, Mao Jun J: Scan-associated distress in lung cancer: Quantifying the impact of "scanxiety". Lung cancer (Amsterdam, Netherlands) 100 : 110-3,2016.
Ahn Peter H, Mitra Nandita, Alonso-Basanta Michelle, Palmer James N, Adappa Nithin D, O'Malley Bert W, Rassekh Christopher, Chalian Ara, Cohen Roger B: Risk of lymph node metastasis and recommendations for elective nodal treatment in squamous cell carcinoma of the nasal cavity and maxillary sinus: a SEER analysis. Acta oncologica (Stockholm, Sweden) 55 (9-10): 1107-1114,2016.